<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>

<head>
    <title>FOLOTYN</title>
    <link href="style.css" rel="stylesheet" type="text/css">
    <script type="text/javascript" src="js/jquery-1.11.1.min.js"></script>
    <script type="text/javascript" src="js/javascript.js"></script>
</head>

<body>
    <div id="fond">
        <div id="cover">
        	<div class="transitive_left transitive-0 logo_block">
	            <div id="logo_bg"></div>
	            <img src="images/logo.png" id="logo">
        	</div>
        	<div>
        		<div id="right_text" class="transitive_right transitive-1">
        			relapsed/ <br/> refractory ptcl <br/> <span class="white_text">Case Study</span>
        		</div>
        		<div id="left_text" class="transitive_opacity transitive-2">
	        		<span class="violet_text">Indications and Usage </span><br/>

	        		FOLOTYN is indicated for the treatment of relapsed or refractory peripheral T-cell lymphoma. This indication is based on overall response rate. Clinical benefit such as improvement in progression-free survival or overall survival has not been demonstrated.
        		</div>
        	</div>
        	<div id="modes">
				FOL-1298-14 (Long) <br/>
        		FOL-1322-14 (Medium) <br/>
        		FOL-1323-14 (Short)
        	</div>

        </div>
    </div>
</body>

</html>
